Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Valeant Pharmaceuticals International Inc. (T.BHC) had Debt to Equity Ratio of -67.13 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-63.05M |
|
-- |
|
-- |
|
-- |
|
2.12B |
|
-- |
|
228.89M |
|
228.89M |
|
-98.68M |
|
-98.68M |
|
-98.68M |
|
-98.68M |
|
2.12B |
|
3.93B |
|
368.00M |
|
368.00M |
|
-0.17 |
|
-0.17 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
36.35B |
|
-- |
|
-- |
|
-- |
|
36.79B |
|
-441.33M |
|
-23.25B |
|
-441.33M |
|
367.84M |
|
| Cash Flow Statement Financials | |
2.19B |
|
-622.25M |
|
-1.19B |
|
1.32B |
|
1.65B |
|
327.57M |
|
205.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.86 |
|
-- |
|
-- |
|
1.02 |
|
|
Debt to Equity Ratio |
-67.13 |
71.10% |
|
16.06% |
|
16.06% |
|
29.80% |
|
1.74% |
|
-0.48% |
|
1.73B |
|
-- |
|
-- |
|
-- |
|
0.36 |
|
1.74 |
|
4.50 |
|
81.15 |
|
22.36% |
|
0.42% |
|
-0.27% |
|
-0.39% |
|
-1.20 |
|
4.69 |
|
5.95 |
|